000 01231 a2200373 4500
005 20250512021823.0
264 0 _c19880401
008 198804s 0 0 eng d
022 _a0300-0664
024 7 _a10.1111/j.1365-2265.1987.tb01171.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRobinson, B G
245 0 0 _aThe effect of o,p'-DDD on adrenal steroid replacement therapy requirements.
_h[electronic resource]
260 _bClinical endocrinology
_cOct 1987
300 _a437-44 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdrenal Gland Neoplasms
_xdrug therapy
650 0 4 _aAdrenal Insufficiency
_xblood
650 0 4 _aAdrenocorticotropic Hormone
_xblood
650 0 4 _aAdult
650 0 4 _aDexamethasone
_xpharmacokinetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMitotane
_xadverse effects
700 1 _aHales, I B
700 1 _aHenniker, A J
700 1 _aHo, K
700 1 _aLuttrell, B M
700 1 _aSmee, I R
700 1 _aStiel, J N
773 0 _tClinical endocrinology
_gvol. 27
_gno. 4
_gp. 437-44
856 4 0 _uhttps://doi.org/10.1111/j.1365-2265.1987.tb01171.x
_zAvailable from publisher's website
999 _c2835926
_d2835926